LEGEND BIOTECH CORP's ticker is and the CUSIP is 52490G902. A total of 5 filers reported holding LEGEND BIOTECH CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,495,000 | +14725.5% | 31,000 | -84.7% | 0.00% | -100.0% |
| Q4 2022 | $10,084 | -99.9% | 202,000 | -15.3% | 0.00% | 0.0% |
| Q3 2022 | $9,731,000 | -25.8% | 238,500 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $13,118,000 | +51.4% | 238,500 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $8,667,000 | +603.5% | 238,500 | +695.0% | 0.00% | – |
| Q2 2021 | $1,232,000 | – | 30,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 84,200 | $4,631,000 | 0.01% |
| SIMPLEX TRADING, LLC | 58,900 | $3,239,000 | 0.00% |
| JPMORGAN CHASE & CO | 238,500 | $13,118,000 | 0.00% |
| JANE STREET GROUP, LLC | 55,400 | $3,047,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |